Dobutamine In Dextrose Injection, Solution
Product Images NDC 0409-0025

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Dobutamine In Dextrose (NDC 0409-0025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Dobutamine Hydrochloride (Dobutamine 01)

Chemical structure of Dobutamine Hydrochloride showing two phenol rings connected by an ethyl chain with hydroxy and amine groups. The image includes the molecular formula C18H23NO3 · HCl and molecular weight 337.85.*

FDA Label Image

Structural Formula Dextrose (Dobutamine 02)

Chemical structure of Dobutamine in Dextrose showing the molecular arrangement including hydroxyl groups and water of hydration (H2O).*

FDA Label Image

Hospira Logo (Dobutamine 03)

FDA Label Image

Hospira Logo (Dobutamine 04)

FDA Label Image

Principal Display Panel (250 mL Bag)

Label for Dobutamine in 5% Dextrose Injection, USP, 500 mg/250 mL (2000 mcg/mL) single-dose container. It includes detailed ingredient information, warnings about sulfites, storage instructions, and distributor details for Hospira, Inc., Lake Forest, IL. The label also shows volume measurement markings and regulatory icons.*

FDA Label Image

Principal Display Panel (250 mL Bag Overwrap)

Label for Dobutamine in 5% Dextrose Injection, USP, 500 mg/250 mL (2,000 mcg/mL) solution in a 250 mL single-dose container. The label includes detailed drug contents, warnings about sulfites, storage instructions, and manufacturer information from Hospira, Inc. The product is marked for intravenous use and contains stabilizers and sodium metabisulfite.*

FDA Label Image

Principal Display Panel (250 mL Bag)

Dobutamine in 5% Dextrose Injection, USP 250 mg/250 mL (1,000 mcg/mL) single-dose container label. The label includes ingredient details, stabilizers, usage instructions, storage conditions, and warnings about sulfites. Distributed by Hospira, Inc., Lake Forest, IL.*

FDA Label Image

Principal Display Panel (250 mL Bag Overwrap)

Label for Dobutamine in 5% Dextrose Injection, USP, strength 250 mg/250 mL (1,000 mcg/mL) in a 250 mL single-dose container. The label includes instructions to tear at the notch to open and contains detailed ingredient and storage information. Distributed by Hospira, Inc., the product is made in Italy.*

FDA Label Image

Principal Display Panel (250 mL Bag)

Label for Dobutamine in 5% Dextrose Injection, USP, 1,000 mg/250 mL (4,000 mcg/mL) in a 250 mL single-dose container. The label includes dosage strength, active ingredients, stabilizers, pH range, storage instructions, warnings about sulfites, and manufacturer information for Hospira, Inc. The label also features volume markers and barcode.*

FDA Label Image

Principal Display Panel (250 mL Bag Overwrap)

Label for Dobutamine in 5% Dextrose Injection, USP, 1,000 mg/250 mL (4,000 mcg/mL) in a 250 mL container. The label includes directions to tear at the notch to open and displays a barcode. It is distributed by Hospira, Inc. and manufactured in Italy. The label also has warnings and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.